Home
Dashboard
Growth Program
Growth VC
Curated content

Startups & Scaleups
Corporates
Job board
Investors
Transactions

More organizations

Matching tool
Investment heatmap

Contact
FAQ
Privacy

Companies
Adaptimmune
Team
Team

Adaptimmune

Develops therapies to treat cancer. Learn more

Launch date

2008

Employees

501-1000 people

Market cap

$284m

Enterprise valuation

$116m (Public information from Sep 2024)

Share price

$1.04 ADAP

Company register number 06456741

Milton England (HQ)

http://www.adaptimmune.com/

https://twitter.com/adaptimmune https://www.linkedin.com/company/adaptimmune/

View job openings

B2C
manufacturing
health
biotechnology

hard tech
biotechnology
horizon europe
biotech and pharma
spinout
oncology
verified unicorns and $1b exits
intellectual property
from $1b exit to zebra

Authorizing premium user...